{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:27:09Z","timestamp":1769578029359,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["TAMOP-4.2.4.A\/2-11\/1-2012-0001"],"award-info":[{"award-number":["TAMOP-4.2.4.A\/2-11\/1-2012-0001"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["GINOP-2.3.2-15-2016-00050"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00050"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1862-6","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T15:04:16Z","timestamp":1555340656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis"],"prefix":"10.1186","volume":"21","author":[{"given":"Szil\u00e1rd","family":"P\u00f3liska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timea","family":"Besenyei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edit","family":"V\u00e9gh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Hamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"V\u00e1ncsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00f3ra","family":"Bodn\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ria","family":"Csumita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Kerekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Zahuczky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"4","key":"1862_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nrrheum.2012.16","volume":"8","author":"G Kerekes","year":"2012","unstructured":"Kerekes G, Soltesz P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Vegh E, Shoenfeld Y, McInnes I, Szekanecz Z. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012;8(4):224\u201334.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1862_CR2","first-page":"398","volume":"35","author":"G Kerekes","year":"2008","unstructured":"Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, Csipo I, Sipka S, Seres I, Paragh G, et al. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol. 2008;35(3):398\u2013406.","journal-title":"J Rheumatol"},{"issue":"1","key":"1862_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3899\/jrheum.090667","volume":"37","author":"MIKE J.L. PETERS","year":"2009","unstructured":"Peters MJ, van Eijk IC, Smulders YM, Serne E, Dijkmans BA, van der Horst-Bruinsma IE, Nurmohamed MT. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol. 2010;37(1):161-6.","journal-title":"The Journal of Rheumatology"},{"issue":"2","key":"1862_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","volume":"38","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum. 2008;38(2):67\u201370.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1862_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3899\/jrheum.100668","volume":"38","author":"N Bodnar","year":"2011","unstructured":"Bodnar N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Nemethne ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltesz P, et al. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol. 2011;38(4):723\u20139.","journal-title":"J Rheumatol"},{"issue":"6","key":"1862_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","volume":"88","author":"C Gonzalez-Juanatey","year":"2009","unstructured":"Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, Martin J, Llorca J, Gonzalez-Gay MA. The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore). 2009;88(6):358\u201365.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"1862_CR7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/qjmed\/hcq152","volume":"103","author":"MP Karampetsou","year":"2010","unstructured":"Karampetsou MP, Liossis SN, Sfikakis PP. TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future. QJM. 2010;103(12):917\u201328.","journal-title":"QJM"},{"issue":"9602","key":"1862_CR8","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370(9602):1861\u201374.","journal-title":"Lancet"},{"issue":"3","key":"1862_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nrrheum.2011.13","volume":"7","author":"CL Verweij","year":"2011","unstructured":"Verweij CL. Pharmacogenetics: anti-TNF therapy in RA--towards personalized medicine? Nat Rev Rheumatol. 2011;7(3):136\u20138.","journal-title":"Nat Rev Rheumatol"},{"issue":"2\u20133","key":"1862_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12026-013-8405-z","volume":"56","author":"Z Szekanecz","year":"2013","unstructured":"Szekanecz Z, Mesko B, Poliska S, Vancsa A, Szamosi S, Vegh E, Simkovics E, Laki J, Kurko J, Besenyei T, et al. Pharmacogenetics and pharmacogenomics in rheumatology. Immunol Res. 2013;56(2\u20133):325\u201333.","journal-title":"Immunol Res"},{"issue":"1","key":"1862_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncprheum0072","volume":"2","author":"BN Cronstein","year":"2006","unstructured":"Cronstein BN. Pharmacogenetics in the rheumatic diseases, from pret-a-porter to haute couture. Nat Clin Pract Rheumatol. 2006;2(1):2\u20133.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"9","key":"1862_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrrheum.2011.117","volume":"7","author":"L Davila","year":"2011","unstructured":"Davila L, Ranganathan P. Pharmacogenetics: implications for therapy in rheumatic diseases. Nat Rev Rheumatol. 2011;7(9):537\u201350.","journal-title":"Nat Rev Rheumatol"},{"key":"1862_CR13","first-page":"15","volume":"3","author":"B Mesko","year":"2010","unstructured":"Mesko B, Poliska S, Szegedi A, Szekanecz Z, Palatka K, Papp M, Nagy L. Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets. BMC Med Genet. 2010;3:15.","journal-title":"BMC Med Genet"},{"issue":"4","key":"1862_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.molmed.2010.12.004","volume":"17","author":"B Mesko","year":"2011","unstructured":"Mesko B, Poliska S, Nagy L. Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases. Trends Mol Med. 2011;17(4):223\u201333.","journal-title":"Trends Mol Med"},{"issue":"3\u20134","key":"1862_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11568-008-9017-x","volume":"1","author":"H Aziz","year":"2007","unstructured":"Aziz H, Zaas A, Ginsburg GS. Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Med. 2007;1(3\u20134):105\u201312.","journal-title":"Genomic Med"},{"issue":"6","key":"1862_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/gm463","volume":"5","author":"B Mesko","year":"2013","unstructured":"Mesko B, Poliska S, Vancsa A, Szekanecz Z, Palatka K, Hollo Z, Horvath A, Steiner L, Zahuczky G, Podani J, et al. Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn\u2019s disease. Genome Med. 2013;5(6):59.","journal-title":"Genome Med"},{"issue":"5","key":"1862_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3899\/jrheum.110961","volume":"39","author":"B Mesko","year":"2012","unstructured":"Mesko B, Poliska S, Szamosi S, Szekanecz Z, Podani J, Varadi C, Guttman A, Nagy L. Peripheral blood gene expression and IgG glycosylation profiles as markers of tocilizumab treatment in rheumatoid arthritis. J Rheumatol. 2012;39(5):916\u201328.","journal-title":"J Rheumatol"},{"issue":"2","key":"1862_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","volume":"45","author":"J Kurko","year":"2013","unstructured":"Kurko J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z. Genetics of rheumatoid arthritis - a comprehensive review. Clin Rev Allergy Immunol. 2013;45(2):170\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"1862_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tig.2012.03.001","volume":"28","author":"AJ Lusis","year":"2012","unstructured":"Lusis AJ. Genetics of atherosclerosis. Trends Genet. 2012;28(6):267\u201375.","journal-title":"Trends Genet"},{"issue":"4","key":"1862_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11883-012-0245-0","volume":"14","author":"AJ Marian","year":"2012","unstructured":"Marian AJ. The enigma of genetics etiology of atherosclerosis in the post-GWAS era. Curr Atheroscler Rep. 2012;14(4):295\u20139.","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"1862_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/art.23149","volume":"58","author":"TM Farragher","year":"2008","unstructured":"Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 2008;58(2):359\u201369.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1862_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/art.22482","volume":"57","author":"MA Gonzalez-Gay","year":"2007","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57(1):125\u201332.","journal-title":"Arthritis Rheum"},{"key":"1862_CR23","doi-asserted-by":"publisher","first-page":"29713","DOI":"10.1038\/srep29713","volume":"6","author":"S Remuzgo-Martinez","year":"2016","unstructured":"Remuzgo-Martinez S, Genre F, Lopez-Mejias R, Ubilla B, Mijares V, Pina T, Corrales A, Blanco R, Martin J, Llorca J, et al. Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis. Sci Rep. 2016;6:29713.","journal-title":"Sci Rep"},{"issue":"11","key":"1862_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","volume":"15","author":"R Lopez-Mejias","year":"2016","unstructured":"Lopez-Mejias R, Castaneda S, Gonzalez-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martinez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev. 2016;15(11):1013\u201330.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"1862_CR25","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1862_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM Gestel van","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39(1):34\u201340.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1862_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1862_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10067-009-1118-y","volume":"28","author":"P Soltesz","year":"2009","unstructured":"Soltesz P, Der H, Kerekes G, Szodoray P, Szucs G, Danko K, Shoenfeld Y, Szegedi G, Szekanecz Z. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol. 2009;28(6):655\u201362.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1862_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/01.STR.28.3.665","volume":"28","author":"SD Kanters","year":"1997","unstructured":"Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke. 1997;28(3):665\u201371.","journal-title":"Stroke"},{"issue":"3","key":"1862_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/HJH.0b013e3282f314f7","volume":"26","author":"J Baulmann","year":"2008","unstructured":"Baulmann J, Schillings U, Rickert S, Uen S, Dusing R, Illyes M, Cziraki A, Nickering G, Mengden T. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens. 2008;26(3):523\u20138.","journal-title":"J Hypertens"},{"issue":"7","key":"1862_CR31","first-page":"1329","volume":"35","author":"O Timar","year":"2008","unstructured":"Timar O, Soltesz P, Szamosi S, Der H, Szanto S, Szekanecz Z, Szucs G. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol. 2008;35(7):1329\u201333.","journal-title":"J Rheumatol"},{"issue":"21","key":"1862_CR32","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","volume":"112","author":"Y Shoenfeld","year":"2005","unstructured":"Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112(21):3337\u201347.","journal-title":"Circulation"},{"issue":"1","key":"1862_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76(1):17\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1862_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/BOR.0b013e3283457524","volume":"23","author":"R Vries de","year":"2011","unstructured":"de Vries R. Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol. 2011;23(3):227\u201332.","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"1862_CR35","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30(11):1205\u201313.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1862_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333\u20138.","journal-title":"Nat Genet"},{"issue":"8","key":"1862_CR37","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/art.23637","volume":"58","author":"MA Gonzalez-Gay","year":"2008","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Llorca J, Ollier WE, Martin J. Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: comment on the article by Farragher et al. Arthritis Rheum. 2008;58(8):2584 author reply 2584-2585.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1862_CR38","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/ar4608","volume":"16","author":"M Garcia-Bermudez","year":"2014","unstructured":"Garcia-Bermudez M, Lopez-Mejias R, Genre F, Castaneda S, Llorca J, Gonzalez-Juanatey C, Corrales A, Ubilla B, Miranda-Filloy JA, Pina T, et al. Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. Arthritis Res Ther. 2014;16(4):R146.","journal-title":"Arthritis Res Ther"},{"key":"1862_CR39","doi-asserted-by":"publisher","first-page":"21906","DOI":"10.1038\/srep21906","volume":"6","author":"JA Diepen van","year":"2016","unstructured":"van Diepen JA, Jansen PA, Ballak DB, Hijmans A, Rutjes FP, Tack CJ, Netea MG, Schalkwijk J, Stienstra R. Genetic and pharmacological inhibition of vanin-1 activity in animal models of type 2 diabetes. Sci Rep. 2016;6:21906.","journal-title":"Sci Rep"},{"issue":"8","key":"1862_CR40","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1194\/jlr.M065565","volume":"57","author":"YW Hu","year":"2016","unstructured":"Hu YW, Wu SG, Zhao JJ, Ma X, Lu JB, Xiu JC, Zhang Y, Huang C, Qiu YR, Sha YH, et al. VNN1 promotes atherosclerosis progression in apoE-\/- mice fed a high-fat\/high-cholesterol diet. J Lipid Res. 2016;57(8):1398\u2013411.","journal-title":"J Lipid Res"},{"issue":"10","key":"1862_CR41","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/art.11279","volume":"48","author":"E Trysberg","year":"2003","unstructured":"Trysberg E, Nylen K, Rosengren LE, Tarkowski A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum. 2003;48(10):2881\u20137.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1862_CR42","first-page":"1807","volume":"15","author":"M Gronblad","year":"1988","unstructured":"Gronblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1988;15(12):1807\u201310.","journal-title":"J Rheumatol"},{"issue":"6","key":"1862_CR43","first-page":"689","volume":"16","author":"AM Salih","year":"1998","unstructured":"Salih AM, Nixon NB, Dawes PT, Mattey DL. Prevalence of antibodies to neurofilament polypeptides in patients with rheumatoid arthritis complicated by peripheral neuropathy. Clin Exp Rheumatol. 1998;16(6):689\u201394.","journal-title":"Clin Exp Rheumatol"},{"key":"1862_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuroimage.2013.05.066","volume":"82","author":"P Kochunov","year":"2013","unstructured":"Kochunov P, Charlesworth J, Winkler A, Hong LE, Nichols TE, Curran JE, Sprooten E, Jahanshad N, Thompson PM, Johnson MP, et al. Transcriptomics of cortical gray matter thickness decline during normal aging. Neuroimage. 2013;82:273\u201383.","journal-title":"Neuroimage"},{"issue":"2","key":"1862_CR45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1089\/gtmb.2016.0112","volume":"21","author":"N Li","year":"2017","unstructured":"Li N, Ma J, Li K, Guo C, Ming L. Different contributions of CDKAL1, KIF21B, and LRRK2\/MUC19 polymorphisms to SAPHO syndrome, rheumatoid arthritis, ankylosing spondylitis, and seronegative spondyloarthropathy. Genet Test Mol Biomarkers. 2017;21(2):122\u20136.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"1862_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/ard.55.5.298","volume":"55","author":"S Dooley","year":"1996","unstructured":"Dooley S, Herlitzka I, Hanselmann R, Ermis A, Henn W, Remberger K, Hopf T, Welter C. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis. 1996;55(5):298\u2013304.","journal-title":"Ann Rheum Dis"},{"key":"1862_CR47","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.redox.2014.02.007","volume":"2","author":"E Sozen","year":"2014","unstructured":"Sozen E, Karademir B, Yazgan B, Bozaykut P, Ozer NK. Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis. Redox Biol. 2014;2:732\u20138.","journal-title":"Redox Biol"},{"issue":"1","key":"1862_CR48","first-page":"124","volume":"291","author":"Z Han","year":"1999","unstructured":"Han Z, Boyle DL, Aupperle KR, Bennett B, Manning AM, Firestein GS. Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther. 1999;291(1):124\u201330.","journal-title":"J Pharmacol Exp Ther"},{"issue":"22","key":"1862_CR49","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1042\/CS20160465","volume":"130","author":"KHM Kwok","year":"2016","unstructured":"Kwok KHM, Cheng KKY, Hoo RLC, Ye D, Xu A, Lam KSL. Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice. Clin Sci (Lond). 2016;130(22):2087\u2013100.","journal-title":"Clin Sci (Lond)"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1862-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:07:44Z","timestamp":1586819264000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1862-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1862"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1862-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"See above, cover page.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The Medical Research Council of Hungary gave ethical approval for this study (No. 9732-2\/2012\/EHR). In addition, the Institutional Review Board of the University of Debrecen Faculty of Medicine also approved the protocol. The study that was in compliance with the Helsinki Declaration.Ethical approval (No. 1046-63\/2015) was obtained from the Regional\/Institutional Review Board of Miskolc University. All patients signed informed consent. The study was performed according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No data that could identify single patients are presented therefore this consent is not needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"94"}}